In the Hepa 1–6 tumor model, injection of entolimod 1 h prior to TNF/D-GalN combination treatment also achieved mouse survival (protected against TNF/D-GalN toxicity), but affected tumor growth somewhat differently. This evidence concerns the gene TNF and neoplasm.